I believe the answer would be 2 to 3 years, given they are able to get internal finacing after a round of internal financing.

When/if the above happens, then the T36 would be a Therputic medication and the Company will be a great candidate for take over at many multiples of what it is trading at.

For the above to happen Alda needs to get its commercial products on the shelve to generate interest in a PP at higher prices. This PP would be then used to finance the short term plans (getting the product in shape for trails, getting FDA trails ready...etc).

As we progress and after having sales going, the Company would start internally financing their activities via their internal cash.

The above will result in low share dilution and if/when all the above happens and they get Health Canada's approval and the FDA's, then you can be looking at a Company worth at least 200-300M dollars and more if its on a take over rader.

So if you are a long-term investor willing to wait 2 to 3 years on your money, Alda will be one to watch and hold.

MMN